Searchable abstracts of presentations at key conferences in endocrinology

ea0014p459 | (1) | ECE2007

Prostate specific antigen (PSA) in women with menstrual disturbances and mastopathy

Radowicki Stanislaw , Kunicki Michal

The aim of the study was to assess free and total prostate-specific antigen-PSA in serum of women with menstrual ditubances and mastopathy.Material and methods: We examined 176 patients who were admitted to the Departement of Gynaecological Endocrinology with benign breasts pathology. According to clinical examination and sonographical findings women were didvided into two groups: • group I: 114 with fibrocystic breast disease...

ea0032p18 | Adrenal cortex | ECE2013

The diagnosis of nonclassical congenital adrenal hyperplasia due to 21 hydroxylase deficiency in woman can be established by genetic testing or urine steroid profile analysis but not by ACTH stimulation test

Ambroziak Urszula , Kepczynska-Nyk Anna , Nowak Karolina , Malunowicz Ewa Maria , Morawska Emilia , Kunicki Michal , Bednarczuk Tomasz

Backgroud: ACTH stimulation test is considered the basic diagnostic tool in the diagnosis of nonclassical congenital adrenal hyperplasia due to 21 hydroxylase deficiency (CAH). The cut off of 17OHP stimulation recommended for diagnosis is 10 ng/ml.Aim: To assess whether the recommended threshold of 17OHP after ACTH stimulation confirms nonclassical CAH among woman with hyperandrogenism and elevated basal 17OHP level.Material and Me...

ea0032p592 | Female reproduction | ECE2013

Overnight 1 mg dexamethasone androgen suppression test is useful diagnostic tool in hyperandrogenism.

Ambroziak Urszula , Kepczynska-Nyk Anna , Nowak Karolina , Morawska Emilia , Kunicki Michal , Bednarczuk Tomasz

Introduction: Low dose dexamethasone (DEX) androgen suppression test (LDDAST) is considered a tool to distinguish between the sources of androgen excess and to exclude/confirm autonomy of androgen overproduction.Aim: To assess whether 1 mg DST can be used instead of LDDAST.Materials and methods: Thirty-three consecutive women with hyperandrogenism age 18–38 years undergone overnight 1 mg DEX androgen suppression test and LDDAS...